Effect of ribotype on all-cause mortality following Clostridium difficile infection

Journal of Hospital Infection

Volumn 84, Issue 3, 2013, Pages 235-241

  Inns, T ^a   Gorton, R ^a   Berrington, A ^b   Sails, A ^a   Lamagni, T ^a   Collins, J ^c   Perry, J ^c   Hill, K ^c   Magee, J ^a   Gould, K ^c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Clostridium difficile; England; Epidemiology; Mortality; Ribotyping

Indexed keywords

AGED; ARTICLE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COHORT ANALYSIS; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; RETROSPECTIVE STUDY; RIBOTYPING; SEASONAL VARIATION; SURVIVAL; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COHORT STUDIES; ENGLAND; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; RIBOTYPING; SURVIVAL ANALYSIS;

EID: 84879782076     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.04.008     Document Type: Article

References (36)

1. Bauer M.P., Notermans D.W., van Benthem B.H., et al. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377(9759):63-73.
2. Barbut F., Jones G., Eckert C. Epidemiology and control of Clostridium difficile infections in healthcare settings. Curr Opin Infect Dis 2011, 24:370-376.
3. Duerden B.I. Contribution of a government target to controlling Clostridium difficile in the NHS in England. Anaerobe 2011, 17:175-179.
4. Office for National Statistics Deaths involving Clostridium difficile: England and Wales, 2006 to 2010 23 August 2011, ONS, London.
5. Healthcare Commission Investigation into outbreaks of Clostridium difficile at Maidstone and Tunbridge Wells NHS Trust October 2007, HC, London.
6. Wiegand P.N., Nathwani D., Wilcox M.H., Stephens J., Shelbaya A., Haider S. Clinical and economic burden of Clostridium difficile infection in Europe: a systematic review of healthcare-facility-acquired infection. JHosp Infect 2012, 81:1-14.
7. Pépin J., Valiquette L., Alary M.-E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 2004, 171:466-472.
8. Gulihar A., Nixon M., Jenkins D., Taylor G.J.S. Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality. Injury 2009, 40:746-751.
9. McGowan A.P., Lalayiannis L.C., Sarma J.B., Marshall B., Martin K.E., Welfare M.R. Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008. JHosp Infect 2011, 77:11-15.
10. O'Neill G.L., Ogunsola F.T., Brazier J.S., Duerden B.I. Modification of a PCR ribotyping method for application as a routine typing scheme for Clostridium difficile. Anaerobe 1996, 2:205-209.
11. Stubbs S.L., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. JClin Microbiol 1999, 37:461-463.
12. Vanek J., Hill K., Collins J., et al. Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period. JHosp Infect 2012, 81:209-212.
13. Pépin J., Saheb N., Coulombe M.-A., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254-1260.
14. Merrigan M., Venugopal A., Mallozzi M., et al. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J.Bacteriol 2010, 192:4904-4911.
15. Warny M., Pepin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366(9491):1079-1084.
16. Rupnik M., Grabnar M., Geric B. Binary toxin producing Clostridium difficile strains. Anaerobe 2003, 9:289-294.
17. Goorhuis A., Van der Kooi T., Vaessen N., et al. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin Infect Dis 2007, 45:695-703.
18. Sundram F., Guyot A., Carboo I., Green S., Lilaonitkul M., Scourfield A. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors. JHosp Infect 2009, 72:111-118.
19. Goorhuis A., Debast S.B., Dutilh J.C., et al. Type-specific risk factors and outcome in an outbreak with 2 different Clostridium difficile types simultaneously in 1 hospital. Clin Infect Dis 2011, 53:860-869.
20. Huttunen R., Vuento R., Syrjänen J., Tissari P., Aittoniemi J. Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study. Int J Infect Dis 2012, 16:532-535.
21. Wilson V., Cheek L., Satta G., et al. Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis 2010, 50:e77-e81.
22. Sirard S., Valiquette L., Fortier L.-C. Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. JClin Microbiol 2011, 49:4040-4046.
23. Morgan O.W., Rodrigues B., Elston T., et al. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 2008, 3:e1812.
24. Wilcox M.H., Shetty N., Fawley W.N., et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis 2012, 55:1056-1063.
25. Chief Medical Officer. Letter: Changes to the mandatory healthcare associated infection surveillance system for Clostridium difficile associated diarrhoea from April 2007. UK Government archive; 11 April 2007.
26. Health Protection Agency Quarterly Epidemiological Commentary: Mandatory MRSA, MSSA and E.coli bacteraemia, and C.difficile infection data (up to January-March 2012) 2012, HPA, London.
27. Zou G. Amodified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159:702-706.
28. Akaike H. Information theory and an extension of the maximum likelihood principle. Proceedings of the Second International Symposium on Information Theory 1973, 267-281. Akadémiai Kiadó, Budapest. B.N. Petrov, F. Csákt (Eds.).
29. Cox C., Chu H., Schneider M.F., Muñoz A. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution. Statist Med 2007, 26:4352-4374.
30. Office for National Statistics Excess winter mortality in England and Wales, 2010/11 (provisional) and 2009/10 (final) released 22 November 2011, ONS, London.
31. Welfare M.R., Lalayiannis L.C., Martin K.E., Corbett S., Marshall B., Sarma J.B. Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. JHosp Infect 2011, 79:359-363.
32. Hota S.S., Achonu C., Crowcroft N.S., Harvey B.J., Lauwers A., Gardam M.A. Determining mortality rates attributable to Clostridium difficile infection. Emerg Infect Dis 2012, 18:305-307.
33. Jhung M.A., Thompson A.D., Killgore G.E., et al. Toxinotype V. Clostridium difficile in humans and food animals. Emerg Infect Dis 2008, 14:1039-1045.
34. Goorhuis A., Bakker D., Corver J., et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008, 47:1162-1170.
35. Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
36. Miller M., Gravel D., Mulvey M., et al. Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin Infect Dis 2010, 50:194-201.